Cite
MLA Citation
Dustin W. Wooten et al.. “Baseline amyloid and tau PET imaging characteristics in the ongoing phase 2 study of tilavonemab in early Alzheimer's disease.” Alzheimer's & dementia, vol. 17, n.d., p. n/a. http://access.bl.uk/ark:/81055/vdc_100178296059.0x000027